rTMS to improve BCI control for upper‑limb rehabilitation after chronic stroke
Official title: ETUDE DE L'AMELIORATION DU CONTROLE DES INTERFACES CERVEAU-MACHINE PAR LA CONNECTIVITE FONCTIONNELLE ET LA STIMULATION MAGNETIQUE TRANSCRANIENNE REPETEE DANS LA REEDUCATION MOTRICE DU MEMBRE SUPERIEUR APRES UN ACCIDENT VASCULAIRE CHRONIQUE
Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT06951035 · Data updated 2026-11-12
This tests whether repeated transcranial magnetic stimulation (rTMS) helps people with chronic stroke use a brain–computer interface (BCI) to improve movement in their affected arm.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France Government |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | April 25, 2025 |
| Main results expected | April 2028 |
| Study ends | April 2029 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT06951035 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are right‑handed adults aged 18–85, more than six months after a single stroke, with distal upper‑limb motor deficit (UE‑FMA < 53) and visible finger extension (mRC ≥ 2) who can give informed consent.
✕Probably not a fit
Patients with fixed severe spasticity (mAS = 4), absent finger extension, major language/comprehension impairment, degenerative neurological disease, recent botulinum toxin to the forearm/hand, craniectomy, or scalp/skin lesions preventing EEG/stimulation are unlikely to benefit or to be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial enrolls adults with chronic single‑stroke upper‑limb motor deficits and visible finger extension to receive repeated transcranial magnetic stimulation combined with BCI‑guided motor training. Treatments are delivered at the Institut du Cerveau in Paris over multiple sessions while researchers record BCI control and clinical motor scores. Outcomes include changes in upper‑extremity Fugl‑Meyer scores and BCI performance measures to link physiological effects with functional gains. The protocol excludes patients with severe spasticity, major comprehension deficits, degenerative neurological disease, or skin/scalp lesions that prevent EEG or stimulation.
Why it matters
Potential benefit: If successful, this approach could improve voluntary arm and hand movement and make BCI assistance more effective for people with chronic stroke.
How similar studies have gone: Previous rTMS trials have shown variable motor gains with limited evidence, and combining rTMS with BCI control is a relatively novel approach with promising but unproven results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Single Stroke older than 6 months * Distal motor deficit of the upper limb (UE-FMA score \< 53) with visible extension of the fingers (Medical Research Council (mRC) score ≥ 2) * Right-handed * Between 18 and 85 years of age * Having given their written consent Exclusion Criteria: * Patient under tutorship or guardianship, under safeguard of justice, deprived of liberty, pregnant or breast feeding women * Life-threatening pathologies or compromising follow-up during the study period * Trouble of understanding : score below 12/15 in the Boston Diagnostic Aphasia Examination (BDAE) order execution test * Fixed spasticity of finger or carpal flexors (mAS score = 4) or botulinum toxin injection less than 12 weeks old in the forearm or hand * History of degenarative neurological pathology or craniectomy * Deficient upper limb skin lesion preventing use of mucle stimulation * Skin lesion of the scalp preventing EEG placement * Participation in biomedical therapeutic research that may affect the recovery of the deficient hand during the study * Patient who has previously participated in a therapeutic study rTMS (excluding single shock) or a BCI * Patient who does not wish to be informed of a brain abnormality discovered accidentally on MRI
Where it's running
-
Institut du Cerveau
Paris, France Recruiting
Study contacts
- Study coordinator: Paolo BARTOLOMEO, MD, INSERM DR2
- Email: paolo.bartolomeo@upmc.fr
- Phone: +33 1 57 27 41 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Thiamine to reduce brain injury in adults with alcohol use disorder
This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.
-
Investigating microcirculation with non-invasive devices in adults with or at risk for CKD
This study tests two non-invasive devices (HEMI and SPG-NINOX) to see how small blood vessels behave in adults with or at risk for chronic kidney disease, hypertension, or type 2 diabetes.
-
Virological Monitoring of Seasonal Respiratory Infections in France
This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.
-
Finding early biological signs of ALS
This project will test whether a molecular fingerprint in spinal fluid can detect ALS early in people with ALS gene mutations, in early ALS patients, and in matched controls.
-
Child cognitive and emotional resilience after the November 13 attacks and intergenerational effects of trauma
This project tests whether parents' exposure to the November 13, 2015 attacks affects their children's thinking, emotions, brain function, and stress hormones using brain scans, psychological and cognitive tests, and saliva samples.
-
Cortical Excitability and DLPFC Structure in Healthy Adults Using TMS, EEG, and High-Field MRI
This study tests how reproducible brain signals from transcranial magnetic stimulation relate to the anatomy of the left prefrontal cortex in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.